GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer
Q. Wu, W. Alawi, G. Deblois…·C. H. Arrowsmith
This study shows that GLUT1 inhibition reduces growth of RB1-positive TNBC cells with high glycolytic activity and low OXPHOS, suggesting a therapeutic target in this subset.